Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infection: the new problems.

R H Rubin1, N E Tolkoff-Rubin

  • 1Infectious Disease Unit, Massachusetts General Hospital, Boston 02114.

Transplantation Proceedings
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplant infectious disease as a subspecialty: does outlining how we train define who we are?

Transplant infectious disease : an official journal of the Transplantation Society·2010
Same author

Transplant infectious disease: a moving target.

Transplant infectious disease : an official journal of the Transplantation Society·2008
Same author

Individualization in the management of fungal disease in the transplant recipient.

Transplant infectious disease : an official journal of the Transplantation Society·2007
Same author

Principles of antimicrobial therapy in the transplant recipient.

Transplant infectious disease : an official journal of the Transplantation Society·2007
Same author

The persistent challenges of bacterial infections in the transplant recipient.

Transplant infectious disease : an official journal of the Transplantation Society·2006
Same author

Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy.

Transplant infectious disease : an official journal of the Transplantation Society·2006
Same journal

Living Donor Kidney Transplantation: Comparison of Graft Survival Between First and Second Transplants-A Single-Center Experience.

Transplantation proceedings·2026
Same journal

Acute Rejection Mediated by Preformed Anti-HLA-C Antibody in a Kidney Transplant Patient: A Case Report.

Transplantation proceedings·2026
Same journal

Liver Transplantation for Metastatic Neuroendocrine Tumors: A Single-Center Experience in a Brazilian Referral Center.

Transplantation proceedings·2026
Same journal

Analysis of the Cost of Maintaining Effective Donors and Nondonors of Organs and Tissues in Intensive Care Units.

Transplantation proceedings·2026
Same journal

Adolescence and Pediatric Heart Transplantation: Impact of Non-Adherence on Mortality: A Single-Center Experience.

Transplantation proceedings·2026
Same journal

Impact of Family-Based Care on the Outcome of Brain Death and Humanization in the Process of Multiple Organ Donation: Case Report.

Transplantation proceedings·2026
See all related articles

Infection risk in transplant patients hinges on immunosuppression and exposure. Different immunosuppressants impact viral infections like cytomegalovirus and hepatitis uniquely, influencing patient outcomes.

Area of Science:

  • Transplant Infectious Diseases
  • Immunosuppression and Infection Risk

Background:

  • Infection remains a significant challenge in clinical transplantation despite advances.
  • Understanding infection risk requires analyzing immunosuppression and patient exposures.

Purpose of the Study:

  • To explore the interplay between immunosuppressive agents and infectious disease risks in transplant recipients.
  • To highlight the differential effects of immunosuppressants on viral infections.

Main Methods:

  • Comparative analysis of immunosuppressive agents (cyclosporine vs. antithymocyte globulin) in a murine cytomegalovirus infection model.
  • Review of epidemiologic exposures, including nosocomial hazards.

Main Results:

  • Cyclosporine promotes viral replication but has low reactivation potential; antithymocyte globulin has potent reactivation but minimal impact on replication.

Related Experiment Videos

  • Immunosuppressive drug timing, type, dose, and duration significantly affect infectious disease outcomes.
  • Nosocomial exposures in hospitals are increasingly recognized as significant risks.

    • Conclusions:

    • Viral infections, particularly cytomegalovirus and hepatitis, remain critical concerns for transplant patients.
    • Future challenges include managing human immunodeficiency virus (HIV) in transplant recipients.
    • Tailoring immunosuppression strategies is crucial for mitigating infection risks.